Trials / Completed
CompletedNCT01456026
Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes
Acute Effects of Food Advanced Glycation Endproducts on Macrovascular Function in Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Profil Institut für Stoffwechselforschung GmbH · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Recent evidence supports detrimental effects of advanced glycation endproducts (AGE) on vascular function (VF). Though, the effect of AGE-modified proteins alone on vascular function remained unknown. Therefore, the aim of our study is to investigate the effects of heat-treated, glycated beta-lactoglobulins (BLG) on vascular function in subjects with type 2 diabetes mellitus (T2DM) and to compare it to non-glycated, heat-treated BLG.
Detailed description
In a double-blind, controlled, randomized, cross-over manner, 19 subjects with T2DM will receive on 2 different days beverages containing either glycated, heat-treated BLG or non-glycated, heat-treated BLG. Macrovascular (brachial ultrasound of flow mediated dilatation -FMD) and microvascular function (laser-doppler measurements of reactive hyperemia at the hand) at baseline (T0), as well as 90 (T90) and 180 (T180) minutes after each beverage will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glycated beta-lactoglobulins. | oral, 20 g, single administration |
| DIETARY_SUPPLEMENT | Non-glycated beta-lactoglobulins | 20 g, oral, single administration, |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2011-10-20
- Last updated
- 2011-10-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01456026. Inclusion in this directory is not an endorsement.